Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Parkinsonian Disorders

fluorodeoxyglucose f18 has been researched along with Parkinsonian Disorders in 64 studies

Research

Studies (64)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	18 (28.13)	29.6817
2010's	34 (53.13)	24.3611
2020's	12 (18.75)	2.80

Authors

Authors	Studies
Ko, JH; Strafella, AP	1
Eidelberg, D; Ležaić, L; Perovnik, M; Rebec, E; Rus, T; Studen, A; Tang, CC; Tomše, P; Trošt, M	1
Allocca, M; Arnone, A; Berti, V; Bessi, V; De Cristofaro, MT; Di Dato, R; Ferrari, C; Laghai, I; Lombardi, G; Nerattini, M; Polito, C; Puccini, G; Ramat, S; Rubino, F; Sorbi, S	1
Ahlskog, JE; Ali, F; Botha, H; Carlos, AF; Clark, HM; Coon, EA; Dickson, DW; Josephs, KA; Koga, S; Lowe, V; Pham, NTT; Sekiya, H; Trejo-Lopez, JA; Whitwell, JL	1
Al-Fatly, B; Anton-Rodriguez, JM; Carter, SF; Gerhard, A; Herholz, K; Hinz, R; Kobylecki, C; Kübler, D; McDonald, KR; Thompson, JC	1
Cumming, P; Huang, SC; Li, H; Navab, N; Rominger, A; Schwaiger, M; Shi, K; Wang, J; Weber, W; Wu, P; Yakushev, I; Zhao, Y; Zuo, C	1
Eidelberg, D; Grmek, M; Jensterle, L; Pirtošek, Z; Rus, T; Tang, C; Tomše, P; Trošt, M	1
Ali, F; Botha, H; Clark, HM; Duffy, JR; Josephs, KA; Lowe, VJ; Machulda, MM; Seckin, ZI; Strand, EA; Thu Pham, NT; Utianski, RL; Whitwell, JL	1
Authier, FJ; Chalaye, J; David, JP; Emsen, B; Evangelista, E; Gracies, JM; Itti, E; Lerman, L; Villafane, G	1
Choi, YY; Dhawan, V; Eidelberg, D; Fahn, S; Gupta, DK; O'Shea, SA; Poston, KL; Schindlbeck, KA; Tang, CC; Vonsattel, JP	1
Chieregato, M; Guerra, UP; Magni, E; Morassi, M; Morbelli, S; Nici, S; Palmerini, F; Savelli, G; Vogrig, A	1
Masrori, P; Van Damme, P; Van Laere, K; Van Weehaeghe, D	1
An, YS; Park, DG; Yoon, JH	1
Artiko, V; Brajkovic, L; Castiglioni, I; Gallivanone, F; Jecmenica-Lukic, M; Jesic, A; Kostic, V; Odalovic, S; Radovic, B; Sobic-Saranovic, D; Stefanova, E; Stojiljkovic, M; Trajkovic, G	1
Frings, L; Hellwig, S; Meyer, PT; Rücker, G	1
Boudousq, V; Castelnovo, G; Collombier, L; Renard, D; Thouvenot, E	1
Agosta, F; Altomare, D; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Gandolfo, F; Garibotto, V; Nestor, P; Nobili, F; Orini, S; Walker, Z	1
Brockmann, K; Hoffmann, J; Klopfer, J; Reimold, M; Schulte, C; Synofzik, M; Wilke, C; Zimmermann, M	1
Chung, SJ; Kim, J; Kim, JS; Kim, K; Kim, MJ; Kim, YJ; Lee, C; Moon, H; Oh, JS; Oh, M; Park, KW; Ryu, HS; You, S	1
Bastianello, M; Biafore, F; Depetris, TS; Peralta, C	1
De Jong, BM; Dierckx, RA; Leenders, KL; Mudali, D; Renken, RJ; Roerdink, JB; Teune, LK	1
Baudrexel, S; Grünwald, F; Hilker, R; Klein, JC; Middendorp, M; Penndorf, B; Seifried, C; Steinmetz, H	1
Akdemir, ÜÖ; Kapucu, LÖ; Karakuş, A; Tokçaer, AB	1
Amtage, F; Buchert, R; Guschlbauer, B; Hellwig, S; Meyer, PT; Niesen, WD; Reinhard, M; Tüscher, O; Weiller, C	1
Benatar, M; Delong, MR; Factor, SA; Freeman, A; Jinnah, HA; Montilla, J; Revuelta, GJ; Wichmann, T	1
Appel-Cresswell, S; Dickson, DW; Dinelle, K; Farrer, MJ; McCormick, SE; McKenzie, J; Rajput, A; Rajput, AH; Robinson, CA; Silva, V; Sossi, V; Stoessl, AJ; Thompson, C; Vilariño-Güell, C	1
Allen, PJ; Amtage, F; Eidelberg, D; Feigin, A; Hanspal, E; Heinen, L; Hellwig, S; Leenders, KL; Meyer, PT; Niethammer, M; Poston, KL; Tang, CC; Vonsattel, JP	1
Choi, CG; Chung, SJ; Kim, HS; Kim, JS; Kim, SJ; Lee, CS; Oh, J; Yoon, RG	1
Amaral, LL; Barsottini, OG; Belezia, AB; Marussi, VH; Oliveira, AS; Pedroso, JL; Yared, J	1
Azulay, JP; Carron, R; Delfini, M; Eusebio, A; Fluchère, F; Gesquière-Dando, A; Guedj, E; Loundou, A; Mundler, L; Regis, J; Witjas, T	1
Amtage, F; Buchert, R; Frings, L; Hellwig, S; Meyer, PT; Rijntjes, M; Spehl, TS; Tüscher, O; Vach, W; Weber, WA; Weiller, C	1
Calabria, F; Cascini, GL; Ciccariello, G; Falcone, C; Schillaci, O	1
Antenora, A; Barbato, S; Bilo, L; De Michele, G; De Rosa, A; Esposito, M; Pappatà, S; Peluso, S	1
Berg, D; Biskup, S; Pomper, JK; Puskás, C; Synofzik, M; Wilke, C	1
Brandel, JP; Brefel Courbon, C; Dumas, H; Guedj, E; Lesage, S; Ory Magne, F; Pariente, J; Payoux, P; Peoc'h, K; Puel, M; Saint-Aubert, L; Vital, A	1
Brandt, V; Dhawan, V; Eidelberg, D; Gordon, ML; Mattis, PJ; Nazem, A; Niethammer, M; Sako, W; Tang, CC	1
Alongi, P; Caminiti, SP; Cerami, C; Comi, G; Gianolli, L; Majno, L; Perani, D; Volontè, MA	1
Fukuda, H; Hirayama, K; Hosokai, Y; Ishioka, T; Itoyama, Y; Mori, E; Nishio, Y; Sawada, Y; Suzuki, K; Takahashi, S; Takeda, A	1
Lee, YJ; Li, H; Li, KW; Lin, SZ; Liu, RS; Peng, HF; Shyu, WC; Su, CY; Wang, HJ	1
Alessandro, S; Brusa, L; Ceravolo, R; Costa, A; Galati, S; Iani, C; Marzetti, F; Peppe, A; Pierantozzi, M; Placidi, F; Romigi, A	1
Dhawan, V; Eckert, T; Eidelberg, D; Fahn, S; Feigin, A; Frucht, S; Gudesblatt, M; Lesser, M; Poston, KL; Tang, CC; Vonsattel, JP	1
Afzal, W; Apostolova, I; Buchert, R; Buhmann, C; Derlin, T; Hesse, S; Klutmann, S; Meyer, PT; Wilke, F	1
Schwarz, J	1
Barcia, E; Fernández, M; Fernández-Carballido, A; Negro, S; Slowing, K	1
Harada, H; Notoya, M; Ono, K; Sakai, K; Shima, K; Yamada, M	1
Goldstein, DS; Holmes, C; Sharabi, Y	1
Amtage, F; Buchert, R; Hellwig, B; Hellwig, S; Kreft, A; Meyer, PT; Rijntjes, M; Spehl, TS; Tüscher, O; Vach, W; Weber, WA; Weiller, C; Winkler, C; Winz, OH	1
Batla, A; D'Souza, MM; Dhawan, V; Jaimini, A; Kushwaha, S; Mondal, A; Peng, S; Saw, S; Sharma, R; Tripathi, M	1
Brooks, DJ; Chaudhuri, KR; Hu, MT; Jarosz, J; Yaguez, L	1
Choe, B; Juh, R; Kim, J; Moon, D; Suh, T	1
Asanuma, K; Carbon, M; Dhawan, V; Eidelberg, D	1
Atsuta, N; Fukatsu, H; Hirayama, M; Ito, H; Ito, K; Kato, T; Mabuchi, N; Sobue, G; Watanabe, H	1
Brien, MO; Giunti, P; Khan, NL; Lees, AJ; Piccini, P; Scherfler, C; Sweeney, MG; Wood, NW	1
Barnes, A; Dhawan, V; Eckert, T; Eidelberg, D; Feigin, AS; Frucht, S; Gordon, MF	1
Abele, M; Bares, R; Bürk, K; Dohmen, BM; Klockgether, T; Machulla, HJ; Minnerop, M; Reimold, M; Wüllner, U	1
Cotelli, M; Fazio, F; Garibotto, V; Meola, G; Perani, D; Sansone, V; Vitelli, E	1
Hummel, T; Kitzler, H; Landis, B; Mueller, A; Reichmann, H; Reuner, U	1
Amthauer, H; Felix, R; Harnack, D; Klaffke, S; Kuhn, AA; Kupsch, A; Plotkin, M	1
Arvanitakis, Z; Boeve, BF; Caviness, JN; Cheshire, WP; Dickson, DW; Hutton, ML; Lin, SC; Liss, JM; Pooley, RA; Slowinski, J; Strongosky, AJ; Tsuboi, Y; Uitti, RJ; Witte, RJ; Wszolek, ZK	1
Beuthien-Baumann, B; Donix, M; Herholz, K; Herting, B; Holthoff, VA; Lampe, JB; Pöttrich, K; Reichmann, H; Triemer, A; von Kummer, R	1
Momose, T	1
Aalto, S; Chang, JW; Lee, KO; Lee, MS; Lyoo, CH; Oh, SH; Rinne, JO	1
Brown, N; Eckert, T; Eidelberg, D; Feigin, A; Frucht, S; Lin, T; Ma, Y; Tang, C	1
Hirono, N; Hosaka, K; Ishii, K; Mori, E; Mori, T; Sakamoto, S; Sasaki, M	1

Reviews

8 review(s) available for fluorodeoxyglucose f18 and Parkinsonian Disorders

Article	Year
Metabolic imaging and plasticity. Handbook of clinical neurology, 2022, Volume: 184 Topics: Brain; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography	2022
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:12 Topics: Cognitive Dysfunction; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Parkinsonian Disorders; Radiopharmaceuticals	2017
Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9 Topics: Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography	2018
Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders. Current neurology and neuroscience reports, 2019, 06-29, Volume: 19, Issue:8 Topics: Apathy; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Movement Disorders; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon	2019
Atypical parkinsonism in C9orf72 expansions: a case report and systematic review of 45 cases from the literature. Journal of neurology, 2016, Volume: 263, Issue:3 Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Brain; C9orf72 Protein; DNA Repeat Expansion; Electrooculography; Family Health; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography; Proteins; PubMed; Young Adult	2016
Non-motor functions in parkinsonian patients implanted in the pedunculopontine nucleus: focus on sleep and cognitive domains. Journal of the neurological sciences, 2010, Feb-15, Volume: 289, Issue:1-2 Topics: Brain Mapping; Cognition Disorders; Deep Brain Stimulation; Electrodes, Implanted; Executive Function; Fluorodeoxyglucose F18; Humans; Memory, Short-Term; Neuropsychological Tests; Parkinsonian Disorders; Pedunculopontine Tegmental Nucleus; Positron-Emission Tomography; Sleep Wake Disorders; Subthalamic Nucleus	2010
[Nuclear medicine imaging in patients with Parkinson's syndrome: an update]. Der Nervenarzt, 2010, Volume: 81, Issue:10 Topics: Animals; Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Energy Metabolism; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Nerve Degeneration; Neurons; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Receptors, Dopamine; Regional Blood Flow; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	2010
[Positron emission tomography with FDG and newly developed tracers for the assessment of brain metabolism and synaptic function in neurological disorders]. Brain and nerve = Shinkei kenkyu no shinpo, 2007, Volume: 59, Issue:5 Topics: Adult; Brain; Brain Neoplasms; Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Nervous System Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Synaptic Transmission	2007

Trials

2 trial(s) available for fluorodeoxyglucose f18 and Parkinsonian Disorders

Article	Year
Brain 18F-FDG PET imaging in the differential diagnosis of parkinsonism. Clinical nuclear medicine, 2014, Volume: 39, Issue:3 Topics: Adult; Aged; Atrophy; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography	2014
Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. Journal of the neurological sciences, 2002, Jul-15, Volume: 199, Issue:1-2 Topics: Brain; Caudate Nucleus; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Mesencephalon; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Parkinsonian Disorders; Predictive Value of Tests; Reference Values; Somatosensory Cortex; Supranuclear Palsy, Progressive; Tomography, Emission-Computed	2002

Article

Year

Brain 18F-FDG PET imaging in the differential diagnosis of parkinsonism.

Clinical nuclear medicine, 2014, Volume: 39, Issue:3

Topics: Adult; Aged; Atrophy; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography

2014

Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.

Journal of the neurological sciences, 2002, Jul-15, Volume: 199, Issue:1-2

Topics: Brain; Caudate Nucleus; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Mesencephalon; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Occipital Lobe; Parietal Lobe; Parkinsonian Disorders; Predictive Value of Tests; Reference Values; Somatosensory Cortex; Supranuclear Palsy, Progressive; Tomography, Emission-Computed

2002

Other Studies

54 other study(ies) available for fluorodeoxyglucose f18 and Parkinsonian Disorders

Article	Year
Abnormal metabolic covariance patterns associated with multiple system atrophy and progressive supranuclear palsy. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 2022, Volume: 98 Topics: Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive	2022
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:9 Topics: Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Parkinsonian Disorders; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies	2022
Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy. Parkinsonism & related disorders, 2022, Volume: 101 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Multimodal Imaging; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Supranuclear Palsy, Progressive	2022
Structural and metabolic correlates of neuropsychological profiles in multiple system atrophy and Parkinson's disease. Parkinsonism & related disorders, 2023, Volume: 107 Topics: Diffusion Tensor Imaging; Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Neuropsychological Tests; Parkinson Disease; Parkinsonian Disorders	2023
A 3D Deep Residual Convolutional Neural Network for Differential Diagnosis of Parkinsonian Syndromes on Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2019, Volume: 2019 Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neural Networks, Computer; Parkinsonian Disorders; Positron-Emission Tomography	2019
Differential diagnosis of parkinsonian syndromes: a comparison of clinical and automated - metabolic brain patterns' based approach. European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:12 Topics: Brain; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Parkinsonian Disorders; Supranuclear Palsy, Progressive	2020
The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study. Parkinsonism & related disorders, 2020, Volume: 81 Topics: Aged; Apraxias; Brain; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Hypokinesia; Language Tests; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Rigidity; Parkinsonian Disorders; Positron-Emission Tomography; Postural Balance; Radiopharmaceuticals; Speech Disorders; Supranuclear Palsy, Progressive; Tremor	2020
Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes. Medicine, 2020, Nov-06, Volume: 99, Issue:45 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinsonian Disorders; Patient Care Management; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2020
Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism. European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:11 Topics: Brain; Clinical Decision-Making; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Multiple System Atrophy; Parkinsonian Disorders; Uncertainty	2021
SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients. Journal of neurology, 2021, Volume: 268, Issue:11 Topics: COVID-19; Encephalitis; Fluorodeoxyglucose F18; Humans; Parkinsonian Disorders; Positron Emission Tomography Computed Tomography; SARS-CoV-2	2021
Distinguishing Primary Lateral Sclerosis from Parkinsonian Syndromes with the Help of Advanced Imaging. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021, 09-01, Volume: 62, Issue:9 Topics: Fluorodeoxyglucose F18; Humans; Parkinsonian Disorders; Tropanes	2021
Serial 18F-FP-CIT and FDG PET in Fulminant Corticobasal Syndrome. Clinical nuclear medicine, 2021, Sep-01, Volume: 46, Issue:9 Topics: Fluorodeoxyglucose F18; Humans; Parkinsonian Disorders; Positron-Emission Tomography; Tropanes	2021
The utility of FDG-PET in the differential diagnosis of Parkinsonism. Neurological research, 2017, Volume: 39, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive	2017
FDG-PET in Creutzfeldt-Jakob disease: Analysis of clinical-PET correlation. Prion, 2017, 11-02, Volume: 11, Issue:6 Topics: Aged; Aged, 80 and over; Ataxia; Codon; Creutzfeldt-Jakob Syndrome; Dystonia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography	2017
Biallelic Parkin (PARK2) mutations can cause a bvFTD phenotype without clinically relevant parkinsonism. Parkinsonism & related disorders, 2018, Volume: 55 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Mutation; Parkinsonian Disorders; Phenotype; Positron-Emission Tomography; Ubiquitin-Protein Ligases	2018
Distinct clinical features of predominant pre-synaptic and trans-synaptic nigrostriatal dysfunction in multiple system atrophy. Journal of the neurological sciences, 2019, Jul-15, Volume: 402 Topics: Adult; Aged; Case-Control Studies; Cerebellar Ataxia; Corpus Striatum; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Middle Aged; Multiple System Atrophy; Neural Pathways; Parkinsonian Disorders; Positron-Emission Tomography; Presynaptic Terminals; Putamen; Substantia Nigra; Tropanes	2019
Validation of parkinsonian disease-related metabolic brain patterns. Movement disorders : official journal of the Movement Disorder Society, 2013, Volume: 28, Issue:4 Topics: Aged; Brain; Brain Mapping; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Supranuclear Palsy, Progressive	2013
The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:3 Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Putamen	2014
Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison. European journal of neurology, 2014, Volume: 21, Issue:6 Topics: Aged; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Radionuclide Imaging; Sensitivity and Specificity; Supranuclear Palsy, Progressive; Ultrasonography, Doppler, Transcranial	2014
An ¹⁸F-FDG PET study of cervical muscle in parkinsonian anterocollis. Journal of the neurological sciences, 2014, May-15, Volume: 340, Issue:1-2 Topics: Adult; Aged; Aged, 80 and over; Dystonia; Electromyography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neck Muscles; Parkinsonian Disorders; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed; Torticollis	2014
Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:13 Topics: Aged; Aged, 80 and over; Brain; Carbon Isotopes; Dopamine Agents; Family Health; Fluorodeoxyglucose F18; Humans; Levodopa; Middle Aged; Molecular Chaperones; Mutation; Parkinsonian Disorders; Positron-Emission Tomography; Tetrabenazine	2014
A disease-specific metabolic brain network associated with corticobasal degeneration. Brain : a journal of neurology, 2014, Volume: 137, Issue:Pt 11 Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Cerebral Cortex; Cerebrum; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Networks and Pathways; Middle Aged; Multiple System Atrophy; Nerve Net; Neurodegenerative Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Supranuclear Palsy, Progressive	2014
The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography. Neuroscience letters, 2015, Jan-01, Volume: 584 Topics: Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Retrospective Studies	2015
PET-CT imaging in a patient with progressive supranuclear palsy. Arquivos de neuro-psiquiatria, 2015, Volume: 73, Issue:4 Topics: Aged; Brain; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive	2015
A preoperative metabolic marker of parkinsonian apathy following subthalamic nucleus stimulation. Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:13 Topics: Aged; Apathy; Brain; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Logistic Models; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography; Subthalamic Nucleus; Treatment Outcome	2015
18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:10 Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lewy Body Disease; Male; Middle Aged; Movement Disorders; Parkinsonian Disorders; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Survival Analysis	2015
A case of Fahr's disease examined by multi-modal imaging. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:13 Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Parkinsonism in adult-onset Rasmussens's encephalitis: a clinical picture presenting as corticobasal syndrome. The International journal of neuroscience, 2016, Volume: 126, Issue:12 Topics: Brain; Encephalitis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinsonian Disorders; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed, Single-Photon	2016
Case report of Lewy body disease mimicking Creutzfeldt-Jakob disease in a 44-year-old man. BMC neurology, 2016, Jul-30, Volume: 16 Topics: 14-3-3 Proteins; Adult; Brain; Cognition Disorders; Creutzfeldt-Jakob Syndrome; Delusions; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Neuroimaging; Parkinsonian Disorders; Positron-Emission Tomography	2016
Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases. Neurology, 2016, Nov-01, Volume: 87, Issue:18 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Brain; Case-Control Studies; Cognition Disorders; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinsonian Disorders; Positron-Emission Tomography; Psychiatric Status Rating Scales; Severity of Illness Index	2016
Evaluation of an optimized [ European journal of neurology, 2017, Volume: 24, Issue:5 Topics: Aged; Aged, 80 and over; Basal Ganglia Diseases; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neurodegenerative Diseases; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity	2017
Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment. Movement disorders : official journal of the Movement Disorder Society, 2009, Apr-30, Volume: 24, Issue:6 Topics: Aged; Brain Mapping; Cerebrovascular Circulation; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinsonian Disorders; Positron-Emission Tomography; Severity of Illness Index; Statistics as Topic	2009
Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model. Journal of neuroscience research, 2009, Volume: 87, Issue:9 Topics: Animals; Antigens, CD34; Biomarkers; Brain-Derived Neurotrophic Factor; Cell Survival; Corpus Striatum; Denervation; Disease Models, Animal; Dopamine; Excitatory Amino Acid Antagonists; Fluorodeoxyglucose F18; GAP-43 Protein; Glucose; Male; Neuronal Plasticity; Oxidopamine; Parkinsonian Disorders; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Recovery of Function; Stem Cells; Substantia Nigra	2009
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. The Lancet. Neurology, 2010, Volume: 9, Issue:2 Topics: Aged; Brain; Brain Mapping; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinsonian Disorders; Pattern Recognition, Automated; Positron-Emission Tomography; Predictive Value of Tests; Psychiatric Status Rating Scales; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity	2010
IBZM SPECT and FDG PET in the differential diagnosis of Parkinsonian syndromes: comparison with respect to inter-rater agreement. Nuklearmedizin. Nuclear medicine, 2010, Volume: 49, Issue:4 Topics: Benzamides; Diagnosis, Differential; Dopamine Antagonists; Fluorodeoxyglucose F18; Humans; Observer Variation; Parkinsonian Disorders; Patient Selection; Positron-Emission Tomography; Pyrrolidines; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon	2010
An effective novel delivery strategy of rasagiline for Parkinson's disease. International journal of pharmaceutics, 2011, Oct-31, Volume: 419, Issue:1-2 Topics: Animals; Antiparkinson Agents; Brain; Delayed-Action Preparations; Disease Models, Animal; Fluorodeoxyglucose F18; Indans; Injections, Intraperitoneal; Lactic Acid; Male; Microspheres; Multimodal Imaging; Parkinsonian Disorders; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Positron-Emission Tomography; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Rotenone; Tomography, X-Ray Computed	2011
Parkinson's disease showing progressive conduction aphasia. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2012, Volume: 33, Issue:2 Topics: Aged; Aphasia; Brain; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Parkinsonian Disorders; Positron-Emission Tomography	2012
Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies. Brain : a journal of neurology, 2012, Volume: 135, Issue:Pt 6 Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Biomarkers; Catecholamines; Dopamine Agents; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Positron-Emission Tomography; Pure Autonomic Failure; ROC Curve	2012
[¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology, 2012, Sep-25, Volume: 79, Issue:13 Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Iodobenzenes; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Supranuclear Palsy, Progressive; Tomography, Emission-Computed, Single-Photon	2012
Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography. Neuroradiology, 2013, Volume: 55, Issue:4 Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; India; Male; Middle Aged; Observer Variation; Parkinsonian Disorders; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity	2013
An imaging study of parkinsonism among African-Caribbean and Indian London communities. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6 Topics: Adult; Aged; Black People; Brain; Cerebral Cortex; Corpus Striatum; Cross-Cultural Comparison; Diagnosis, Differential; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; India; Lewy Body Disease; London; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parkinsonian Disorders; Radiography; Radionuclide Imaging; Supranuclear Palsy, Progressive; West Indies; White People	2002
Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET. European journal of radiology, 2004, Volume: 51, Issue:3 Topics: Aged; Brain; Case-Control Studies; Caudate Nucleus; Cerebellum; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Mesencephalon; Middle Aged; Multiple System Atrophy; Neocortex; Parkinson Disease; Parkinsonian Disorders; Pons; Positron-Emission Tomography; Putamen; Radiopharmaceuticals; Retrospective Studies; Supranuclear Palsy, Progressive; Thalamus	2004
Assessment of disease progression in parkinsonism. Journal of neurology, 2004, Volume: 251 Suppl 7 Topics: Aged; Brain; Carbon Radioisotopes; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Iodine Radioisotopes; Longitudinal Studies; Male; Middle Aged; Movement; Parkinsonian Disorders; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tropanes	2004
Primary lateral sclerosis presenting parkinsonian symptoms without nigrostriatal involvement. Journal of neurology, neurosurgery, and psychiatry, 2004, Volume: 75, Issue:12 Topics: Adult; Aged; Brain; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Hypokinesia; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Neuron Disease; Parkinsonian Disorders; Positron-Emission Tomography; Posture; Radiopharmaceuticals	2004
Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6). Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Calcium Channels; Corpus Striatum; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinsonian Disorders; Pedigree; Phenotype; Point Mutation; Positron-Emission Tomography; Spinocerebellar Ataxias; Substantia Nigra; Trinucleotide Repeat Expansion	2005
FDG PET in the differential diagnosis of parkinsonian disorders. NeuroImage, 2005, Jul-01, Volume: 26, Issue:3 Topics: Aged; Aging; Brain; Brain Mapping; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Multiple System Atrophy; Nerve Degeneration; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Supranuclear Palsy, Progressive	2005
Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6. Archives of neurology, 2005, Volume: 62, Issue:8 Topics: Adult; Binding, Competitive; Biomarkers; Brain; Brain Mapping; Dopamine; Dopamine Plasma Membrane Transport Proteins; Down-Regulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Middle Aged; Nerve Tissue Proteins; Parkinsonian Disorders; Positron-Emission Tomography; Presynaptic Terminals; Spinocerebellar Ataxias	2005
Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism. Journal of neurology, neurosurgery, and psychiatry, 2006, Volume: 77, Issue:3 Topics: Blood Glucose; Brain; Brain Ischemia; Diagnosis, Differential; Dopamine; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Muscle Weakness; Myotonic Dystrophy; Neurologic Examination; Neuropsychological Tests; Parkinsonian Disorders; Positron-Emission Tomography; Statistics as Topic	2006
Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:9 Topics: Adult; Aged; Basal Ganglia; Basal Ganglia Diseases; Blood Glucose; Chromosome Aberrations; Copper; Extrapyramidal Tracts; Female; Fluorodeoxyglucose F18; Genes, Recessive; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurodegenerative Diseases; Olfaction Disorders; Olfactory Pathways; Parkinsonian Disorders; Positron-Emission Tomography; Sensory Thresholds; Statistics as Topic	2006
Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:10 Topics: Aged; Benzamides; Blood Glucose; Brain; Cerebral Cortex; Cocaine; Corpus Striatum; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parietal Lobe; Parkinsonian Disorders; Positron-Emission Tomography; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon; Tropanes	2006
Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism & related disorders, 2007, Volume: 13, Issue:4 Topics: Adult; Asparagine; Cerebral Cortex; Chromosomes, Human, Pair 17; Dementia; Family Health; Female; Fluorodeoxyglucose F18; Humans; Lysine; Male; Middle Aged; Mutation; Neuropsychological Tests; Parkinsonian Disorders; Positron-Emission Tomography; tau Proteins	2007
Prefrontal cortex dysfunction and depression in atypical parkinsonian syndromes. Movement disorders : official journal of the Movement Disorder Society, 2007, Mar-15, Volume: 22, Issue:4 Topics: Aged; Brain Stem; Cerebellum; Cognition Disorders; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple System Atrophy; Neuropsychological Tests; Parietal Lobe; Parkinsonian Disorders; Pilot Projects; Positron-Emission Tomography; Prefrontal Cortex; Radiopharmaceuticals; Severity of Illness Index; Thalamus; Tomography, X-Ray Computed	2007
Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait. Movement disorders : official journal of the Movement Disorder Society, 2007, Nov-15, Volume: 22, Issue:15 Topics: Adult; Aged; Antiparkinson Agents; Brain Mapping; Cerebral Cortex; Combined Modality Therapy; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Levodopa; Male; Middle Aged; Neural Pathways; Parkinsonian Disorders; Positron-Emission Tomography; Radiopharmaceuticals; Subthalamic Nucleus	2007
Abnormal metabolic networks in atypical parkinsonism. Movement disorders : official journal of the Movement Disorder Society, 2008, Apr-15, Volume: 23, Issue:5 Topics: Aged; Brain Stem; Cerebellum; Cohort Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Middle Aged; Multiple System Atrophy; Nerve Net; Parkinsonian Disorders; Positron-Emission Tomography; Putamen; Reference Values; Reproducibility of Results; Supranuclear Palsy, Progressive	2008